Randomized Controlled Clinical study on the efficacy of Vidangadi Lauha on Sthula Madhumeha with special reference to Type II Diabetes Mellitus

Khobarkar Punam Self0 个研究点目标入组 80 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Newly detected patients having fasting blood sugar level more than 126mg/dl and post prandial blood sugar level more than 200mg/dl (A.D.A 2015)
•2. Newly detected patients fulfilling criteria of diagnosis and having signs and symptoms of Sthula Madhumeha (Diabetes Mellitus)
•3. Patients having age between 30 to 70 years
•4. HbA1c up to 9%
•5. Patients having BMI more than 23 will be selected up to 30 (chamukuttan.s.2006)
•6. Those are willing to participate in trial and ready to give written consent.
•7. Patients with controlled Hypertension

•1. Patients having age below 30 and above 70.
•2. Patients with fasting blood sugar level >200mg/dl and post meal blood sugar level >300mg/dl.
•3. HbA1c more than 9%.
•4. Patients having BMI less than 23 and above 30.
•5. Patients who already taken anti Diabetic drugs
•6. Patients having insulin dependent diabetes mellitus and juvenile diabetes
•7. Patients having complications such as vasculopathy, nephropathy, retinopathy and neuropathy.
•8. Those are not willing to participate in trial and not ready to give written consent.
•9. Patients having other systemic complications like hepatic, renal and cardiac problems.
•10. If any complication arises during treatment or if any patient discontinues the treatment these cases will be liable for rejection.
•11. Patients having poorly controlled blood pressure.
•12 .Pregnant and lactating females not included in this study.
•13. Emergency cases in Type 2 Diabetes Mellitus.
•14. Patients who are currently participating in any other clinical trials (since last 6 months)

发起方

Khobarkar Punam Self